IBD The Hidden Tormentor
A recent study has found that Nelson has one of the highest rates of Crohn’s disease in the world. Naomi Arnold reports on the conditions that no-one talks about. Physically, Nelson twins Sarah and Anna Schiefer are alike in almost every way – except one is missing 32 centimetres of her intestines, and the other [...]
Walk for IBD cure
On Saturday, June 22, people from across the Metro area will walk on the Mall, bringing attention to an area of the body many of us shy away from talking about. Take Steps for Crohn’s & Colitis is the nation’s only walk dedicated to finding a cure for inflammatory bowel diseases (IBD), which plagues more [...]
Intense Intestines Foundation NYC Five Boro Bike Tour
Intense Intestines Foundation NYC Five Boro Bike Tour., The Intense Intestines Foundation had a group of riders cycle the NYC Five Boro Bike Tour this year for Crohn’s disease, ulcerative colitis and ostomy awareness. Founder and President Brian Greenberg rode with Board member Keith Gilroy and friends Joe Colavito, Kodi Smith and Kim Petrovich for [...]
Qu Biologics Enrolls First Patient in Phase 1/2 Clinical Trial
Qu Biologics Enrolls First Patient in Phase 1/2 Clinical Trial of QBECO SSI for the Treatment of Crohn’s Disease Vancouver, British Columbia – June 11, 2013 – Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to “reboot” the body’s immune system, announced it has enrolled its first patient in a [...]
My Best Friends Are Germs
Excellent piece in the NY Times Magazine by @michaelpollan It happened on March 7. That’s when I opened my e-mail to find a huge, processor-choking file of charts and raw data from a laboratory located at the BioFrontiers Institute at the University of Colorado, Boulder. Here were the names of the hundreds of bacterial species [...]
AbbVie’s New Crohn’s Disease Drug Candidate
AbbVie’s drug Humira is currently the best-selling medication on the planet, and it is approved to treat a wide range of diseases, including Crohn’s Disease and ulcerative colitis. Recently, the company announced a partnership with a small biotech company called Galapagos to develop a JAK1 inhibitor for Crohn’s Disease. In the following video, health-care analyst [...]
Villous atrophy in Crohn’s disease linked to hip fracture
Villous atrophy in Crohn’s disease linked to hip fracture Healio Researchers evaluated 7,146 patients in Sweden with histologic evidence of Crohn’s disease (CD). All participants had undergone follow-up biopsy between 6 months and 5 years of CD diagnosis. The risk for fracture among patients who experienced … and more » Tags: biopsy, crohn s disease, Crohns, [...]
AbbVie, Galapagos extend JAK1 pact into Crohn’s Disease
AbbVie ($ABBV) has made meds for inflammatory gastrointestinal ills a major theme of its deal-making activities this week. The North Chicago, IL-based drug giant and Belgium’s Galapagos ($GLPG) have agreed to expand their collaboration on an oral JAK1 inhibitor to include Crohn’s disease. Galapagos plans to fund and launch a midstage study of the compound, [...]
Delzicol FDA Approved Treatment of Ulcerative Colitis
Warner Chilcott recently announced that the FDA has approved its new product, Delzicol (mesalamine), for the treatment of mildly to moderately active ulcerative colitis (UC) and for the maintenance of remission of UC. Delzicol, a delayed-release 400-mg capsule, contains the same active ingredient and works in the same way as Asacol, which also is indicated [...]
Crohn’s Disease Diet and Nutrition
PHOENIX — More than a million people in the United States suffer from inflammatory bowel diseases like Crohn’s disease and ulcerative colitis. And while we don’t know what causes them, we do know that genetic and environmental components are at the root of these autoimmune diseases. Crohn’s disease can affect the entire digestive tract while [...]
lunettes: